Infants exposed to opioids and psychotropic drugs during pregnancy have a 30% to 60% higher risk of experiencing neonatal withdrawal, a study has found. That risk doubles when multiple psychotropic ...

Implementing patient navigation services for pregnant individuals with opioid use disorder improves attendance at treatment ...

Although the number of infants diagnosed with neonatal opioid withdrawal syndrome (NOWS) and the number of infants entering foster care have increased substantially in the US since 2009, analyses ...

Rates of neonatal abstinence syndrome surged in recent years, but a newer approach to caring for newborn babies exposed to opioids during pregnancy gets them out of the hospital sooner and with less ...

A new study sheds light on two factors that affect the outcomes for infants with neonatal opioid withdrawal syndrome (NOWS). The article, "Transfer timing and the length of medication weaning for ...

Pediatric researchers at the University of Kentucky found that clonidine, an antihypertensive drug typically used to treat high blood pressure, can be as effective as morphine in treating neonatal ...

Neonatal withdrawal signs have been documented in newborns of mothers treated with antidepressants and are known as a cause of neonatal morbidity. Due to the lack of a common terminology, withdrawal ...

Infants with neonatal opioid withdrawal syndrome (NOWS) had a higher risk of hospital readmission than other newborns, a retrospective cohort study suggested. Among nearly 14 million newborns, the ...

On learning last year she was pregnant with her second child, Cailyn Morreale was overcome with fear and trepidation. “I was so scared,” said Morreale, a resident of the small western North Carolina ...

The woman had used oxycodone for almost a decade but told her doctors she had been sober for two years. She never touched narcotics during her pregnancy, she said, and had completed rehab. But her ...